Ең жақсы Инфузиялық витамин терапиясы дәрігерлері - ЖОҒ-49 дәрігерлер

Др. Пимпа Тантанасригул แพทย์หญิงพิมพา ตันธนศรีกุล

ҚАРТАЮҒА ҚАРСЫ 
 

Білім беру тарихы

2021 Таиландтың Медицина Кеңесінің Қоғамдық Денсаулық сақтау Бөлімінің алдын алу медицинасының дипломы

2019 Гендер бойынша ғылым магистрі, Империал Колледж Лондон, Ұлыбритания (Үкіметтік стипендия, Азаматтық Қызмет Комиссиясы) Американдық Қартаюға және Қалпына келтіру Медицинасының Кеңесі, АҚШ

2018 Дерматология және Дермохирургия сертификаты (Қартаюға қарсы), Джунтендо Университеті, Медицина факультеті, Жапония (Жапон Үкіметінің стипендиясы JiCA)

2016 Таиланд Дерматология Кеңесінің дипломы.Дерматология Институты

2011 Клиникалық Дерматология Магистрі, Кардиф Университеті, Ұлыбритания Тері және Лазерлік Хирургия бойынша Феллоушип Тренинг, Дерматология Институты

Dr. Yeom Jihye is a physician who specializes in dermatology, laser and aesthetic procedures, and obesity medicine. She is a full member of the Korean Society of Aesthetic Plastic Surgery and Laser Medicine. She is a full member of the Korean Society for Obesity and Aesthetic Medicine. She is a lifetime member of the Korean Society for Laser Dermatology and Hair Restoration. She is a full member of the Korean Society of Aesthetic Surgery. She is a full member of the Korean Society of Dermatology, Obesity, and Plastic Surgery. She is also a member of the American Academy of Dermatology (AAD).

She completed the UCLA Clinical Observership Program. She also took part in the BHCHP Volunteer Workshop. She previously served as director at Cellin Clinic Hongdae, Shine Beam, U&I, and Bliv.

Dr. Erkan Davarci is a dermatologist at Medical Park Antalya Hospital Complex. He earned his MD from Ankara University Faculty of Medicine. He completed his dermatology residency at Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital. He then fulfilled his compulsory service at the Ministry of Health’s Kelkit State Hospital.

Clinical practice: general dermatology, cosmetic dermatology, laser and energy-based skin treatments, mole and skin lesion care, botulinum toxin and dermal fillers, skin rejuvenation.

Memberships: Aesthetic and Cosmetic Dermatology Society, Turkish Dermatology Society, Turkish Medical Association.

Dr. Joo-young Park, MD
Chief Medical Director & CEO, BIOFACE Clinic
 

Professional Profile

Board-certified dermatologist and anti-aging specialist with over a decade of clinical and research leadership. Dr. Park combines expertise in laser systems, injectable aesthetics, thread-lift techniques, and regenerative therapies to deliver evidence-based protocols that prioritize patient safety, comfort, and natural, lasting outcomes. A sought-after educator and consultant, he has trained hundreds of clinicians and guided protocol development for leading medical device and biotech firms.

Education & Training

Dermatology Residency, Seoul National University Hospital
Advanced training in laser therapies, injectables, and anti-aging procedures

Medical Student Summer Program, Samsung Medical Center (Sungkyunkwan Univ.)

KSKCS Non-invasive Cosmetic Surgery Course

KCCS Asian Lipoplasty Workshop

Professional Experience

Founder, CEO & Medical Director, BioFace Clinic (2018–Present)
Lead all clinical operations, research initiatives, and strategic growth both domestically and internationally.

QOFill Filler Educator, JW Pharmaceutical (2016–Present)
Deliver hands-on workshops on safe, precise filler injection techniques to over 300 physicians nationwide.

HIFU Lifting Technology Consultant (2017–Present)
Advise device manufacturers on protocol optimization to maximize lift efficacy while minimizing downtime.

Clinical Advisor, L&C BIO (KOSDAQ-listed) (2019–Present)
Design and analyze clinical trials for novel dermatologic injectables.

Clinical Advisor, UTI (Application Specialist)
Provide scientific support and training for UTI’s aesthetic device portfolio.

Technical Consultant, NewThera
Guide R&D and protocol development for next-generation aesthetic injectables.

Invited Lectures & Publications

Invited Speaker, Medical Asia 2016
“Next-Generation Filler Strategies” presented to 500+ regional aesthetic practitioners.

Key Publication:
Kim JW, Li MH, Jang JH, et al.
15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.
Biochem Pharmacol. 2008;76(11):1577–1589.

Academic & Professional Memberships

Korean Academy of Laser Medicine

World Society for Laser Medicine & Surgery

Korean Society for Hair Research

Korean Society of Anti-Aging Dermatology

Korean Society of Obesity & Aesthetic Treatment

Korean Society of Obesity & Body Shaping

Korean Society for Stem Cell Therapy

Korean Society of Primary Care

Select Achievements

Developed research-driven, multi-modal anti-aging protocols integrating lasers, injectables, thread lifts, and stem-cell boosters.

Trained 300+ physicians in advanced filler and HIFU applications, elevating national standards of care.

Received the Korean Society of Aesthetic Medicine’s Excellence in Education Award.

Served as medical advisor on KBS health documentary series and multiple international media features.

Core Competencies

Evidence-Based Protocols: Continuous refinement through outcome analysis of thousands of patient cases

Integrated Anti-Aging: Holistic treatment plans tailored for minimal discomfort and rapid recovery

Educational Leadership: Curriculum design and delivery for clinician workshops and medical symposia

Strategic Consulting: Product development guidance for device manufacturers and biotech firms

Languages & Continuing Education

Languages: Korean (native), English (fluent)

Continuing Education: Regular faculty at international conferences; numerous peer-reviewed publications in leading dermatology journals.

Education:  Azerbaijan Medical University, Pediatrics, 2003-2009, Pediatrician  Ministry of Justice of the Republic of Azerbaijan, Intern, 2009-2010, Anesthesiologistreanimatologist (Intensive Therapy) Work experience:  Liv Bona Dea International Hospital, Emergency Physician June 2019 – present  International SOS (GIM) / BP AGT Caspian Sea "Shah Deniz Bravo" Project, Azerbaijan, Caspian Sea, Field doctor February 2017-November 2019  Azerbaijan National Anti-Doping Agency (AMADA), Azerbaijan, Baku, Doping Control Inspector June 2017  4th Islamic Solidarity Games, Azerbaijan, Baku, Medical consultant of Heydar Aliyev arena, May 2017  International SOS (GIM) / BP AGT Caspian Sea “Deepwater Gunashli” Project, Azerbaijan, Caspian Sea, Field Doctor January 2015 – January 2017  International SOS (GIM), Azerbaijan, Baku, site coordinator April 2014-December 2014  Doctor at the Central Neftchilar Hospital, Baku, Azerbaijan, Reanimation and Intensive Therapy Department (trial period) April-September 2012  Premium Assist Insurance Company, Azerbaijan, Baku, Chief Medical Expert (Night shift) AprilSeptember 2012  Medical intern at the Department of Anesthesiology and Intensive Therapy in various institutions under the Ministry of Justice of the Republic of Azerbaijan, Baku, Azerbaijan, August 2009- July 2010  Medi Club Clinic, Azerbaijan, Baku, Physician Assistant/Emergency paramedic August 2007 – July 2010 

Dr. Nutt Chawalitkul is a medical doctor who specializes in preventive medicine, sexual medicine, clinical sexology, and anti-aging medicine. He earned his diplomas from Thammasat University and is certified by the Thai Medical Council. Dr. Nutt is board certified in Anti-Aging and Regenerative Medicine (A4M) and Nutritional Wellness (ANCB). He is also recognized by the International Board of Lifestyle Medicine (IBLM).

He completed a fellowship in Anti-Aging and Regenerative Medicine at Dhurakij Bundit University. He holds certificates in sedation for aesthetic medicine, genomics medicine, gerontology, and hair restoration using the FUE technique. Dr. Nutt is a member of ISHRS, AAHRS, and Asia FUE. These memberships highlight his expertise in hair restoration surgery.

Published journal articles indexed by SCI, SSCI, and AHCI I. Investigation of the effectiveness of teledermatology in the diagnosis of skin lesions in pediatric patients TaslidereN.,KucukO.S. Revista daAssociacaoMedicaBrasileira (1992),vol.69,no.10,2023 (SCI-Expanded) I . Can a Correct Diagnosis Be Established Using the TeledermatologyMethod? TAŞLIDEREN.,SUKÜÇÜKÖ. ACTADERMATOVENEROLOGICACROATICA,vol.30,no.1,pp.32-39,2022 (SCI-Expanded) I I. Melkersson-Rosenthal syndrome induced by COVID-19: A case report TaşlıdereB.,MehmetajL.,ÖzcanA.B.,GülenB.,TaşlıdereN. AmericanJournalofEmergencyMedicine,vol.41,2021 (SCI-Expanded) IV. Which dermatology patients attend to Dermatology Outpatient Clinics during the SARS-CoV-2 outbreak in Turkey and what happened to them? CENGİZ F.P.,EMİROĞLUN.,BAHALIA.G.,DİZMAND.,TAŞLIDEREN.,AkarslanT.C.,GunesB.,MERTÖ.,KÜÇÜKÖ.S., ONSUNN. DERMATOLOGICTHERAPY,vol.33,no.4,2020 (SCI-Expanded)

Areas of activity: • Research of pathology in gerontological age group (elderly) patients • Clinical nutrition (enteral and parenteral nutrition) • Diabetes mellitus, metabolic syndrome, osteoporosis, thyroid diseases • Arterial hypertension • High body temperature of unknown genesis (fever) • Diseases of the musculoskeletal system, rheumatological diseases • Diseases of the gastrointestinal tract, liver • Disorders of water and electrolyte metabolism, kidney diseases Education: • Higher education - Azerbaijan Medical University, Faculty of General Medicine and Prevention, 2008-2014 • Specialization – Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine Work experience: • Baku State Hospital No. 3, resident physician nephrologist. 2014-2016 • Istanbul Private Bahcelievler Memorial Hospital, specialist in internal medicine. 2021-2022 Research work: (dissertation / defense) • Clinical and laboratory features of patients with acute interstitial nephritis diagnosed during kidney biopsy, factors influencing the etiology and response to treatment. Istanbul University, Istanbul Faculty of Medicine, Department of Nephrology, 2021 Publications:(2) •P343Efficacy of adalimumab mild-to-moderate inflammatory bowel disease: Real-life data from a single-centre experience in the long-term period. January 2020 Journal of Crohns and Colitis DOI: 10.1093/ecco-jcc/jjz203.472 •Concurrent myelomatous pleural effusion and extramedullary mediastinalinvolvement as a relapse manifestation of multiple myeloma. Abstract of the IXth International Eurasian Hematology OncologyCongress17–20October2018Istanbul,Turkey(Concomitant myelomatous pleurisy and extramedullary mediastinal lesion as a recurrent manifestation of multiple myeloma. Abstracts of the IX International Eurasian Oncohematology Congress17–20October2018Istanbul,Türkiye) Memberships in scientific organizations: •Turkish Medical Association

General Practitioner/ Medical Director
certified by American Academy of Anti-Aging Medicine

A credentialed physician, general practitioner, MD has gained valuable

diverse experience and a special interest in Aesthetic Medicine. Dr. Farshad is a

certified member of the American Academy of Anti-Aging Medicine (A4M),

certified in advanced injectables and laser therapy  by the National Council on Laser Certification (NCLC) USA.
 

Dr. Farshad comes from a family of medical practitioners. In 1998, he graduated from Shiraz (Pahlavi) University of Medical Sciences. Since then, having great career achievements in Family Medicine across Canada and UAE, he pursued gaining knowledge and practice in aesthetics. Following his passion he performs with a holistic and professional approach to - as he calls it - “Feel-Good procedures” to turn back the hands of time and help his patients, to meet their desire in looking young, fresh and rejuvenated.

Doctor Farshad is mastered in a myriad of aesthetic procedures including Botox and Dermal filler injections, non-surgical facelift advanced methods and various laser Treatments and Laser Therapy. His vast international and multicultural experience allows him the understanding and balance of East and West when caring and treating patients from all backgrounds and ethnicities.

Besides extensive experience, his obsession with details and unrivalled precision for creating the most outstanding natural results has made him to be able to combine the vision of Art and Aesthetics with the most advanced medical treatments to enhance the natural beauty of each individual.
 

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Доктор Вейсел Озжан эстетикалық және холистикалық медицина саласының маманы. Оның Нишанташы және Бакыркөйдегі үздік клиникаларда 12 жылдан астам тәжірибесі бар. Ол мұқият жұмысы және науқастың жоғары қанағаттанушылығы үшін танымал. Доктор Озжан табиғи және тиімді нәтижелерді ұсынады.

Оның Мезотерапия, Фитотерапия, Хиджама және Озон терапиясы бойынша Түркия Денсаулық сақтау министрлігінен сертификаттары бар. Ол заманауи эстетикалық емдер мен қосымша сауықтыру терапияларын үйлестіреді. Доктор Озжан екі жыл Бас дәрігер ретінде қызмет атқарған. Бұл рөлде ол клиникалық топтарды басқарып, аурухананың бөлімшелерін басқарған.

Ол аурухананың маңызды комитеттерін басқарған, оның ішінде Инфекция, Сапа, Инспекция, Тұрғын үй қауіпсіздігі және Науқастың қауіпсіздігін қамтиды. Ол жоғары медициналық стандарттарға және науқастың қауіпсіздігіне шынайы адал. Доктор Озжан ағылшын тілінде еркін, ал күрд тілінде орта деңгейде сөйлейді. Ол жаңашыл және науқасқа бағытталған әдісі үшін танымал.

Dr. med. Andrea Parafioriti is a specialist in Reconstructive and Aesthetic Plastic Surgery. He has performed over 900 surgeries. He trained for two years at the Di Ivo Pitanguy School of Plastic Surgery. He also specialized in minimally invasive gluteoplasty techniques in France with Dr. Francois Petit.

Dr. Parafioriti has taught future surgeons as a trainer in Palermo, Italy. He is known for his work with advanced protocols using mesenchymal stem cells in surgery and regenerative medicine. His focus on innovation and high standards sets him apart in his field.

Эсра Озбашли дәрігері – сертификатталған гинеколог және жыныс эстетикасы хирургі. Оның 21 жылдан астам тәжірибесі бар және Ыстамбұлдағы жетекші мамандардың бірі болып табылады. Д-р Озбашли минималды инвазивті гинекологиялық және жыныс эстетикасы процедураларымен танымал. Ол жетілдірілген әдістермен роботты хирургия және косметикалық гинекология жасайды.

Оның Жыныс Эстетикасы, Косметикалық Гинекология және da Vinci Роботты Хирургиясы бойынша сертификаттары бар. Д-р Озбашли ECFMG-аккредиттелген. Ол халықаралық журналдарда көптеген мақалалар жариялады және басқа мамандарды даярлады. Оның жұмысы зерттеу мен білім беруге зор міндетін көрсетеді. Д-р Озбашли ағылшын тілінде еркін сөйлейді және пациентке бағытталған күтімді қамтамасыз етеді. Ол ең соңғы технологияны қолданып, пациенттері үшін ең жақсы нәтижелерге қол жеткізеді.

ACADEMIC EXPERIENCE 

2010 Degree of Doctor in Medicine 

2010 Bachelor in Nutritional Sciences 

2018 Member of AMPTI (Mexican Association of Professionals in Intravenous Therapy)

2020 Master Degree in Regenerative Medicine 

2023 Certification of RCG, the more important Medical Community of Regenerative Medicine of Mexico 

PROFESSIONAL EXPERIENCE 

2010 - 2013 Clinical Nutritionist in private hospitals and clinics

2013 - 2015 Nutritionist in the Medical Spa of Papaya Playa Project Hotel in Tulum 

2015 - 2016 Doctor in the Red Cross

2016 - 2018 Medical consultations and Vitamin  IV Drip in the best hotels of Tulum: Be Tulum, Nomade, Casa Malca, Azulik, Papaya Playa Project 

2017 - 2019 Specialst in Healing Wound Clinic with PRP and Stem Cells  

2015 - 2019 Vitamin IV Drip in hotels and private houses

2020 - 2024 Specialist in Regenerative Medicine - Stem Cells

Dr. Lara is a passionate Honduran-born medical doctor with a Mexican heart. She earned her MD at the Catholic University of Honduras and has an Obesity Medicine post-graduate degree from Universidad Iberoamericana in Mexico City. She continued into a Masters in Applied Nutrition with a focus on research at Universidad Iberoamericana in Mexico City where her commitment to staying up-to-date and her passion for evidence-based medicine grew fonder.

She is member of the International Society for Stem Cell Application, SCOPE certified by the World Obesity Federation, and certified for Sport’s and Exercise Nutrition.

Besides her clinical experience within multiple hospital ER’s and private practice, Dr. Lara has vast experience within the Regenerative Medicine area, where her biggest determination is to positively impact lives of her patients. She has also experience in administrative areas within Mexico, where besides overseeing treatments, she is up-to-date with Mexican regulatory laws (COFEPRIS). Her passions involve medicine and sports where she has managed to combine both, in her professional world as well as within her personal life.

I was born in Naples, born in 1981, and I have the best job in the world. Imagine waking up every morning and knowing that on that day you will make someone's dream come true: you will change a man's life forever, you will give birth to a new woman, you will help a girl achieve happiness, a boy gain self-confidence. I am Silvio Ascione, specialist in Plastic, Reconstructive and Aesthetic Surgery. Son of art, from my father, a great man and great plastic surgeon, I learned the complex and enchanting magic of aesthetic plastic surgery. Nourished by art and medical knowledge, I grew up in operating theatres, always behind my father's back who, like the best of masters, passed on to me, a young disciple, the passion for a profession in which art combines to science to create masterpieces. Graduated in Medicine and Surgery in 2005 from the Second University of Naples, qualified in the first session of 2006 and specialized in Plastic, Reconstructive and Aesthetic Surgery at the School of Specialization of the Second University of Naples directed by Prof. Francesco D'Andrea, I am enrolled in the 'Order of Surgeons of Benevento and I obtained a Master's degree in Oncoplastic Surgery and integrated treatments at the University of Genoa.

My experience in the surgical room, however, began much earlier, and it was an intense, very hard journey, characterized by total dedication, constant updating, continuous training: initially internal at the Department of Plastic, Reconstructive and Aesthetic Surgery of the S.U.N., I frequented then the Department of Reconstructive and Aesthetic Plastic Surgery of the Mediterranean Clinic of Naples affiliated with the “Tor Vergata” University of Rome, the A.O.R.N. Major Burns Center Department, directed by Prof. Roberto D'Alessio, the Trauma Center Department of Prof. Antonio Martin.

I regularly participate in all the main national and international Plastic Surgery conferences to stay constantly updated on the technological innovations offered by the market, the cutting-edge products and instruments to be used for my treatments, the new research and the most recent studies in the field of plastic and aesthetic surgery.

I studied and carried out in-depth internships at universities and hospital centers in Spain, France and North America, gaining extraordinary experience on the most advanced surgical techniques, in particular on facial and breast rejuvenation.

​

MY MISSION

My innate passion for surgery, my attention to the care of the image and the harmony of forms, my obsessive precision and attention to detail, my unstoppable research and updating activity, my decades of experience in the most varied spheres of plastic and aesthetic surgery, working side by side with my specialized team, allow me today to boast a curriculum full of successes and satisfactions and to be able to offer my patients a detailed and scrupulous visit, a precise diagnosis, a treatment plan personalized and efficient intervention, agreed on the basis of the patient's needs and desires, highly effective personal techniques and tools to eliminate all types of blemishes, signs of aging or congenital imperfections, through increasingly less invasive interventions and with increasingly natural results.

​

Experience, professionalism, harmony, naturalness: these are the four key points on which I build a relationship that is first human, then professional, with my patient. The choice of plastic or aesthetic surgery does not only involve the decision to undertake a path of external change. For this reason I dedicate myself with dedication and attention to listening to the discomforts and wishes of each of my patients, so that we can plan together the most appropriate intervention for their needs and to achieve the expected result and to accompany them step by step towards a path of external and internal rebirth

Др. Сиринтип Джира-адсай - Қартаюға қарсы медицина және дерматолог

Др. Сиринтип Джира-адсай туралы

Др. Сиринтип Джира-адсай Қартаюға қарсы медицина, дерматология және қалпына келтіру медицинасы саласында танымал маман. Осы саладағы жылдар бойы жинаған тәжірибесімен, ол көптеген пациенттерге жас және сау теріні сақтауға көмектесті.

Мамандығы

Др. Сиринтип Қартаюға қарсы медицина, дерматология және қалпына келтіру медицинасында маманданған. Ол пациенттерге жастық келбетті сақтауға және түрлі тері мәселелерін шешуге көмектесу үшін кең ауқымды емдеу әдістерін ұсынады.

Білімі мен Тәжірибесі

Др. Сиринтип Джира-адсай беделді оқу орнынан медициналық дәрежесін алып, Қартаюға қарсы медицина және дерматология саласында арнайы даярлықтан өтті. Ол өз саласындағы соңғы жаңалықтармен танысуға міндеттенген.

Тәжірибе

Осы саладағы жылдар бойғы тәжірибесімен, Др. Сиринтип әртүрлі тері мәселелері бар көптеген пациенттерді сәтті емдеп шықты. Ол Қартаюға қарсы медицина және дерматология саласындағы шеберлігімен танымал.

Жұмыс клиникасы

Др. Сиринтип Джира-адсай Бангкок, Таиландтағы Asia Cosmetic Hospital клиникасында жұмыс істейді. Клиника, қартаюға қарсы және дерматологиялық емдеуді іздейтін пациенттерге ең жақсы күтімді ұсыну үшін заманауи қондырғылармен жабдықталған.

Толық ақпарат немесе Др. Сиринтип Джира-адсаймен кездесу жазылу үшін, Asia Cosmetic Hospital-ге хабарласыңыз.

• Specialize on Hair Transplantation with DHI Technique. 
• Speaker of Hansbiomed Thailand
• Instructor hair transplant tranining course for other doctor at MP Academy.
• Instructor Advanced Filler tranining course for other doctor at MP Academy.
• Founder and Director of MP Clinic
• Founder of One Bright Clinic Chiangmai
• Founder of MP Clinic Chiangmai
• Founder of Morepure Clinic Phuket
• Chief Executive Officer of MP Clinic
• Chief Financial Officer of MP Clinic
• Chief Marketing Officer of MP Clinic
• Chief Operating Officer of MP Clinic